Accretion Pha.

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0T8T01010
  • NSEID: ACCPL
  • BSEID:
INR
151.90
6.4 (4.4%)
BSENSE

Jun 24, 03:30 PM

BSE+NSE Vol: 27600

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 329.70% vs NA in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 363.55% vs NA in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 259.94% vs NA in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 355.08% vs NA in Mar 2024

Compare Profit and Loss Results of Accretion Pha.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
57.00
167.00
-110.00
-65.87%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
57.00
167.00
-110.00
-65.87%
Expenditure (Ex Depriciation)
Stock Adjustments
-3.00
-1.00
-2.00
-200.00%
Raw Materials Consumed
43.00
85.00
-42.00
-49.41%
Power & Fuel Cost
0.00
15.00
-15.00
-100.00%
Employee Cost
3.00
13.00
-10.00
-76.92%
Operating Expenses
0.00
13.00
-13.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
14.00
-14.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
1.00
-1.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
45.00
148.00
-103.00
-69.59%
Operating Profit (PBDIT) excl Other Income
11.00
19.00
-8.00
-42.11%
Other Income
0.00
4.00
-4.00
-100.00%
Operating Profit (PBDIT)
11.00
23.00
-12.00
-52.17%
Interest
1.00
6.00
-5.00
-83.33%
Profit before Depriciation and Tax
10.00
17.00
-7.00
-41.18%
Depreciation
0.00
8.00
-8.00
-100.00%
Profit Before Taxation & Exceptional Items
9.00
9.00
0.00
0.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
9.00
9.00
0.00
0.00%
Provision for Tax
2.00
2.00
0.00
0.00%
Profit After Tax
6.00
6.00
0.00
0.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
1.00
81.00
-80.00
-98.77%
Profit Available for appropriations
8.00
87.00
-79.00
-90.80%
Appropriations
8.00
87.00
-79.00
-90.80%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
8.48
6.43
2.05
31.88%
Profit And Loss - Net Sales
Net Sales 57.38 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 329.70% vs NA in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 11.88 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 363.55% vs NA in Mar 2024

Profit And Loss - Interest
Interest 1.44 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 259.94% vs NA in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 6.79 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 355.08% vs NA in Mar 2024